Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipratropium bromide for clozapine-induced hypersalivation
NCT00381589Phase 2Completed
- Sponsor
- Center for Addiction and Mental Health
- Start
- Oct 2006
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ipratropium bromide in hypersalivation, sponsored by Center for Addiction and Mental Health. Primary endpoint: Toronto Nocturnal Hypersalivation Scale. Started Oct 2006; status: completed.
02
Drugs
ipratropium bromide
03
Conditions
hypersalivation
Beyond the preview
Go deeper on NCT00381589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00381589.